Priority 20 from the Neurodevelopmental Disorders Canada PSP
| UNCERTAINTY: What are the beneficial effects of cannabis products and/or medicinal marijuana for individuals with neurodevelopmental disorders? (JLA PSP Priority 20) | |
|---|---|
| Overall ranking | 20 |
| JLA question ID | 0056/20 |
| Explanatory note | Individuals with neurodevelopmental disorders are often in challenging school placements and/or lack proper educational supports. This question aims to better understand the most effective educational practices to meet the academic needs and improve the educational experience and outcomes of students with neurodevelopmental disorders in various school settings. This uncertainty includes investigating the effectiveness and impact of already existing interventions such as inclusive education and modifications/accommodations, and also questions what other strategies and approaches can be used to support students with neurodevelopmental disorders. *Note: there was a specific interest in promoting social connection, learning/development, as well as improving performance in reading and algebra. |
| Evidence | None identified |
| Health Research Classification System category | Mental Health |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | How CBD hemp and medicinal marijuana can treat autism?; How effective is cannabis oil in the treatment of neurodevelopmental disorders? |
| Submitted by | Family members/carers |
| PSP information | |
|---|---|
| PSP unique ID | 0056 |
| PSP name | Neurodevelopmental Disorders (Canada) |
| Total number of uncertainties identified by this PSP. | 63 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | 28 September 2017 |